KEY FEATURES
| Full Name | Sirtuin 1 |
|---|---|
| Synonym | SIR2L1;NAD-dependent deacetylase sirtuin-1; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.19ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human SIRT1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human SIRT1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human SIRT1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human SIRT1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human SIRT1. You can calculate the concentration of Human SIRT1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human SIRT1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.01 | 3.01 | 9.79 | 1 | 2.96 | 10.65 |
| Standard deviation | 0.06 | 0.18 | 0.53 | 0.05 | 0.17 | 0.58 |
| CV(%) | 5.87 | 5.83 | 5.44 | 5.01 | 5.87 | 5.48 |
RECOVERY
The recovery of Human SIRT1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-105 | 99 |
| EDTA plasma (n=8) | 95-109 | 102 |
| Cell culture media (n=8) | 85-99 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human SIRT1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with Sirt1 ELISA Kits
| Jun ELISA Kit | publications with Sirt1 and Jun |
| Ppargc1a ELISA Kit | publications with Sirt1 and Ppargc1a |
| Foxo1 ELISA Kit | publications with Sirt1 and Foxo1 |
| Trp53 ELISA Kit | publications with Sirt1 and Trp53 |
| Foxo3 ELISA Kit | publications with Sirt1 and Foxo3 |
| Hic1 ELISA Kit | publications with Sirt1 and Hic1 |
| Ep300 ELISA Kit | publications with Sirt1 and Ep300 |
| Rps19bp1 ELISA Kit | publications with Sirt1 and Rps19bp1 |
| Kat5 ELISA Kit | publications with Sirt1 and Kat5 |
| Ncor1 ELISA Kit | publications with Sirt1 and Ncor1 |
Pathways associated with Sirt1 ELISA Kit
| AMPK Signaling Pathway | AMPK Signaling Pathway |
| Amphetamine Addiction Pathway | Amphetamine Addiction Pathway |
| Cellular Response To Heat Stress Pathway | Cellular Response To Heat Stress Pathway |
| Cellular Responses To Stress Pathway | Cellular Responses To Stress Pathway |
| Epigenetic Regulation Of Gene Expression Pathway | Epigenetic Regulation Of Gene Expression Pathway |
| FoxO Signaling Pathway | FoxO Signaling Pathway |
| Gene Expression Pathway | Gene Expression Pathway |
| Glucagon Signaling Pathway | Glucagon Signaling Pathway |
Diseases associated with Sirt1 ELISA Kit
| Inflammation | publications with Sirt1 and Inflammation |
| Obesity | publications with Sirt1 and Obesity |
| Insulin Resistance | publications with Sirt1 and Insulin Resistance |
| Diabetes Mellitus | publications with Sirt1 and Diabetes Mellitus |
| Liver Diseases | publications with Sirt1 and Liver Diseases |
| Neurodegenerative Diseases | publications with Sirt1 and Neurodegenerative Diseases |
| Fatty Liver | publications with Sirt1 and Fatty Liver |
| Necrosis | publications with Sirt1 and Necrosis |
| Heart Diseases | publications with Sirt1 and Heart Diseases |
| Atherosclerosis | publications with Sirt1 and Atherosclerosis |
Organs/Tissues associated with Sirt1 ELISA Kit
| Brain | publications with Sirt1 and Brain |
| Heart | publications with Sirt1 and Heart |
| Adipose Tissue | publications with Sirt1 and Adipose Tissue |
| Lung | publications with Sirt1 and Lung |
| Kidney | publications with Sirt1 and Kidney |
| Eye | publications with Sirt1 and Eye |
| Bone Marrow | publications with Sirt1 and Bone Marrow |
| Prostate | publications with Sirt1 and Prostate |
| Embryonic Tissue | publications with Sirt1 and Embryonic Tissue |
| Spleen | publications with Sirt1 and Spleen |